Cargando…
Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa
BACKGROUND: Shwaskas Chintamani Rasa (SKC) and Kas Shwas Hari Rasa (KSH) are the Ayurvedic herbo-mineral formulations. These Ayurvedic formulations contain heavy metals which is the reason of concern and might bring up the safety issue. OBJECTIVE: This research article is aimed to study chronic toxi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471453/ https://www.ncbi.nlm.nih.gov/pubmed/36088824 http://dx.doi.org/10.1016/j.jaim.2022.100615 |
_version_ | 1784789078905978880 |
---|---|
author | Waghmare, Chaitali S. Bidve, Shivcharan Gudi, R.V. Yadav, Santosh Chawda, Mukesh B. Nalawade, Megha L. |
author_facet | Waghmare, Chaitali S. Bidve, Shivcharan Gudi, R.V. Yadav, Santosh Chawda, Mukesh B. Nalawade, Megha L. |
author_sort | Waghmare, Chaitali S. |
collection | PubMed |
description | BACKGROUND: Shwaskas Chintamani Rasa (SKC) and Kas Shwas Hari Rasa (KSH) are the Ayurvedic herbo-mineral formulations. These Ayurvedic formulations contain heavy metals which is the reason of concern and might bring up the safety issue. OBJECTIVE: This research article is aimed to study chronic toxicity of SKC and KSH for safety aspect in Wistar rats. MATERIAL AND METHOD: A study group of 220 healthy rats were divided into six groups. These rats were administered with SKC and KSH formulations where both the formulations were administered for 180 consecutive days. SKC was administered at doses of 58 mg/kg (equivalent to therapeutic dose i.e. TD), 145 mg/kg (2.5 TD), 290 mg/kg (5 TD) and KSH was administered at dose of 58 mg/kg (TD). According to OECD guideline 452, the effect of these formulations was examined on hematology, serum biochemistry and histopathology of various organs. RESULTS: Both the formulations did not produce any signs or symptoms of treatment related toxicity in both male and female Wistar rats at therapeutic dose (TD), 2.5 times TD and 5 times TD. CONCLUSION: Based on these findings, the NOAEL (No observed adverse effect level) for test formulations SKC and KSH tablets in male and female wistar rats concluded to be preclinically safe. |
format | Online Article Text |
id | pubmed-9471453 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94714532022-09-15 Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa Waghmare, Chaitali S. Bidve, Shivcharan Gudi, R.V. Yadav, Santosh Chawda, Mukesh B. Nalawade, Megha L. J Ayurveda Integr Med Original Research Article BACKGROUND: Shwaskas Chintamani Rasa (SKC) and Kas Shwas Hari Rasa (KSH) are the Ayurvedic herbo-mineral formulations. These Ayurvedic formulations contain heavy metals which is the reason of concern and might bring up the safety issue. OBJECTIVE: This research article is aimed to study chronic toxicity of SKC and KSH for safety aspect in Wistar rats. MATERIAL AND METHOD: A study group of 220 healthy rats were divided into six groups. These rats were administered with SKC and KSH formulations where both the formulations were administered for 180 consecutive days. SKC was administered at doses of 58 mg/kg (equivalent to therapeutic dose i.e. TD), 145 mg/kg (2.5 TD), 290 mg/kg (5 TD) and KSH was administered at dose of 58 mg/kg (TD). According to OECD guideline 452, the effect of these formulations was examined on hematology, serum biochemistry and histopathology of various organs. RESULTS: Both the formulations did not produce any signs or symptoms of treatment related toxicity in both male and female Wistar rats at therapeutic dose (TD), 2.5 times TD and 5 times TD. CONCLUSION: Based on these findings, the NOAEL (No observed adverse effect level) for test formulations SKC and KSH tablets in male and female wistar rats concluded to be preclinically safe. Elsevier 2022 2022-09-08 /pmc/articles/PMC9471453/ /pubmed/36088824 http://dx.doi.org/10.1016/j.jaim.2022.100615 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Research Article Waghmare, Chaitali S. Bidve, Shivcharan Gudi, R.V. Yadav, Santosh Chawda, Mukesh B. Nalawade, Megha L. Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa |
title | Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa |
title_full | Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa |
title_fullStr | Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa |
title_full_unstemmed | Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa |
title_short | Evaluation of chronic toxicological profile of herbo-mineral formulations: Shwaskas Chintamani Rasa and its marketed formulation namely Kas Shwas Hari Rasa |
title_sort | evaluation of chronic toxicological profile of herbo-mineral formulations: shwaskas chintamani rasa and its marketed formulation namely kas shwas hari rasa |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471453/ https://www.ncbi.nlm.nih.gov/pubmed/36088824 http://dx.doi.org/10.1016/j.jaim.2022.100615 |
work_keys_str_mv | AT waghmarechaitalis evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa AT bidveshivcharan evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa AT gudirv evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa AT yadavsantosh evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa AT chawdamukeshb evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa AT nalawademeghal evaluationofchronictoxicologicalprofileofherbomineralformulationsshwaskaschintamanirasaanditsmarketedformulationnamelykasshwasharirasa |